4lmq

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "4lmq" [edit=sysop:move=sysop])
Line 3: Line 3:
The entry 4lmq is ON HOLD
The entry 4lmq is ON HOLD
-
Authors: Zhong, Z, Wang, J, Li, B, Xiang, H, Ultsch, M, Coons, M, Wong, T, Chiang, NY, Clark, S, Clark, R, Quintana, L, Gribling, P, Suto, E, Barck, K, Corpuz,R, Yao, J, Takkar, R, Lee, WP, Damico-Beyer, LA, Carano, RD, Adams, C, Kelley, RF, Wang, W., Ferrara, N
+
Authors: Zhong, Z., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., Wong, T., Chiang, N.Y., Clark, S., Clark, R., Quintana, L., Gribling, P., Suto, E., Barck, K., Corpuz, R., Yao, J., Takkar, R., Lee, W.P., Damico-Beyer, L.A., Carano, R.D., Adams, C., Kelley, R.F., Wang, W., Ferrara, N.
Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12
Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

Revision as of 04:18, 1 August 2013

Unreleased structure

The entry 4lmq is ON HOLD

Authors: Zhong, Z., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., Wong, T., Chiang, N.Y., Clark, S., Clark, R., Quintana, L., Gribling, P., Suto, E., Barck, K., Corpuz, R., Yao, J., Takkar, R., Lee, W.P., Damico-Beyer, L.A., Carano, R.D., Adams, C., Kelley, R.F., Wang, W., Ferrara, N.

Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools